DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Sam Altman - 4 Altman - 4 he's - 3 Mark Zuckerberg - 2 it's - 2 Jeff Bezos - 2 He's - 2 I'm - 2
Top related locs:
Silicon Valley New York OpenAI Wall Silicon geroscience OpenAI's San Francisco Meta
Top related orgs:
Biosciences - 4 Business - 3 Service - 3 OpenAI - 2 Retro Biosciences - 2 Bloomberg - 2 Harvard - 1 MIT - 1

Search resuls for: "Retro Biosciences"


13 mentions found


☆ Sam Altman's mission to increase human lifespan with a $180 million shipping container experiment at Retro Biosciences
  + stars: | 2024-03-23 | by ( Hilary Brueck | ) www.businessinsider.com   time to read: +11 min
Called Retro Biosciences, the startup's goal is simple yet supremely ambitious: Add 10 healthy, enjoyable years onto the back end of our lifetimes. But Retro Biosciences actually fits quite neatly into Altman's futuristic worldview. Retro BiosciencesRetro Biosciences sits about 30 miles south of OpenAI's San Francisco headquarters, where ChatGPT was hatched. Joe Betts-LaCroix is the CEO of Retro Biosciences. There are things we already know work super well to improve human longevity, like exercise, diet, faith, and social support.
Persons: Sam Altman, he's, Elon Musk, Mark Zuckerberg, Altman, Instacart —, Joe Betts, LaCroix, isn't, Betts, Retro's, spry, Yamanaka, Shinya Yamanaka, it's, they've, Sora, Thiel, Jeff Bezos, Bezos, Yuri Milner, Billionaire Peter Thiel, He's, Aubrey de Grey, Christian Angermayer, biogerontologist Daniel Promislow, Altman's, Matt Buckley Organizations: Business, OpenAI, Biosciences, Harvard, MIT, Caltech, Extension, Apple, Stanford University, Retro, Bezos, Labs, Billionaire, Cambrian, Retro Biosciences, Bloomberg Locations: geroscience, Silicon Valley, OpenAI's San Francisco, Meta, Golden City, Retro.bio, Redwood City , California, San Diego
☆ It's comeback season for social media
  + stars: | 2024-03-23 | by ( Joi-Marie Mckenzie | Jordan Parker Erb | ) www.businessinsider.com   time to read: +5 min
This story is available exclusively to Business Insider subscribers. But first: Social media is making a comeback. I'm not alone: Sharing on social media has tapered off, Business Insider reported back in 2023, but consuming content hasn't. Now social media platforms — Facebook, Instagram, TikTok, and others — are clamoring to get users to stay just a little while longer. It's clear social media isn't giving up without a fight — and right now, it seems we're OK with that.
Persons: —, Instagram, Tyler Le, edu, Mark Zuckerberg, I'm, Gen Z, Kate Middleton, BBC Studios Kate, Princess, Wales, she's, Read, Andrew Caballero, Reynold, Jenny Chang, Rodriguez Sam Altman, OpenAI, Altman, Pete Ballmer, Abanti Chowdhury, Steve Ballmer's, Pete, didn't, Kristen Wiig's, Joi, Marie McKenzie, Jordan Parker Erb, Dan DeFrancesco, Lisa Ryan Organizations: Service, Business, Dispatch Social, Facebook, BBC Studios, Aurora, Getty, Biosciences, Hulu, Netflix Locations: Finland's, Utsjoki, Lapland, New York
☆ The breathtaking scope of Sam Altman's future AI empire
  + stars: | 2024-03-07 | by ( Darius Rafieyan | ) www.businessinsider.com   time to read: +9 min
If Sam Altman is to achieve his dream of artificial general intelligence in his lifetime, that number will need to double or triple every year for the foreseeable future. These wide-ranging plans for global transformation go far beyond Altman's role as the CEO of generative AI behemoth OpenAI, developer of ChatGPT. EnergyThe first pillar of Altman's grand unified theory of the future rests on energy. Headlining the event was company chairman and investor Sam Altman, who appeared via video call projected on a towered cineplex. And Altman's AGI empire extends beyond just the energy and raw material required to build AGI.
Persons: Sam Altman, he's, Altman, it's, Max, Jack, Sam himself, Sam, David Kirtley, Helion, He's, Joe Betts Lacroix, Lacroix, where's, Joe Biden, Tade Oyerinde, Oyerinde, Ali Ghodsi, Ghodsi Organizations: Nvidia, Business, Elon, Altman, OpenAI, Energy, Bloomberg, Concorde, Wall Street, Retro Biosciences, Capitol, PAC Locations: Silicon Valley, OpenAI, Davos, New York, Redmond , Washington, Washington
☆ It's not just the uber-rich freezing their brains and bodies when they die. An HBO show visited a conference filled with everyday people excited to do it.
  + stars: | 2023-09-24 | by ( Kylie Kirschner | ) www.businessinsider.com   time to read: +5 min
The series finale of HBO's "How To with John Wilson" explored cryonics and the quest for immortality. Sam Altman, Jeff Bezos, Peter Thiel, and Bryan Johnson all invested in anti-aging or cryonics. Get the inside scoop on today’s biggest stories in business, from Wall Street to Silicon Valley — delivered daily. Insider has previously reported on Alcor competitor Cryonics Institute, a more affordable alternative that charges $28,000 for a body to be stored indefinitely. A Cryonics Institute model of the tanks used to store bodies, which are actually stored upside down in practice.
Persons: John Wilson, Sam Altman, Jeff Bezos, Peter Thiel, Bryan Johnson, It's, Wilson, hasn't, Bari Weiss, he's, Johnson Organizations: Service, Alcor, HBO, MIT Technology, Biosciences, Altos Labs Locations: Wall, Silicon, Altos
☆ Sam Altman thinks Silicon Valley has lost its culture of innovation
  + stars: | 2023-09-07 | by ( Kai Xiang Teo | ) www.businessinsider.com   time to read: +3 min
OpenAI's Sam Altman thinks Silicon Valley no longer has an innovation culture. "Before OpenAI, what was the last really great scientific breakthrough that came out of a Silicon Valley company?" Get the inside scoop on today’s biggest stories in business, from Wall Street to Silicon Valley — delivered daily. "There used to be great research that happened in companies in Silicon Valley, Xerox PARC being the obvious example. To this, Altman responded by saying Silicon Valley did have a product innovation culture, but he felt it missed the mark on groundbreaking research.
Persons: OpenAI's Sam Altman, Sam Altman, Altman, Nicolai Tangen, I'm, Marc Andreessen, Andreessen, Horowitz, Matt Miller, Altman's OpenAI, ChatGPT, OpenAI Organizations: Service, Xerox PARC, Norges Bank Investment, Sequoia Capital, Biosciences Locations: Wall, Silicon, Silicon Valley, China, California, OpenAI
☆ Inside OpenAI's Sam Altman's fixation on death and the apocalypse
  + stars: | 2023-05-03 | by ( Melia Russell | Julia Black | ) www.businessinsider.com   time to read: +3 min
Sam Altman, the CEO of OpenAI, spends a lot of time thinking about risk, especially as it relates to AI. One investor friend told Insider that Altman became even more fixated on delaying death when his father died in 2018. One investor friend told Insider that Altman "says we vastly underestimate risk in society." The investor friend told Insider that urgency grew when Altman's father, a real-estate developer, died in 2018. "I don't think anyone can lose your dad young and wish he didn't have more time with him," Altman told Insider.
☆ He's played chess with Peter Thiel, sparred with Elon Musk and once, supposedly, stopped a plane crash: Inside Sam Altman's world, where truth is stranger than fiction
  + stars: | 2023-04-27 | by ( Melia Russell | Julia Black | ) www.businessinsider.com   time to read: +41 min
But, "you do at some point need to start having contact with reality," he told Insider. The plan was still only a rough sketch, Blania told Insider, but that didn't seem to matter to his host. "He always wanted to understand everything at a very deep level," Thrun told Insider in an email. (When asked about guns, Altman told Insider he'd been "happy to have one both times my home was broken into while I was there.") When asked about this, Altman told Insider in an email: "i can guess what that's about; these stories grow crazily inflated over the years of getting re-told!
☆ Sam Altman is building his utopia, whether you want it or not
  + stars: | 2023-04-27 | by ( Melia Russell | Julia Black | ) www.businessinsider.com   time to read: +41 min
Altman told Insider, "We debate our approach frequently and carefully." "I don't think anyone can lose your dad young and wish he didn't have more time with him," Altman told Insider. Altman told Insider that his thinking had evolved since those posts. (When asked about guns, Altman told Insider he'd been "happy to have one both times my home was broken into while I was there.") When asked about this, Altman told Insider in an email: "i can guess what that's about; these stories grow crazily inflated over the years of getting re-told!
☆ This 24-year-old wants to freeze dead pets with the hope that science can one day bring them back to life – and he's got backing from Peter Thiel to get started
  + stars: | 2023-04-17 | by ( Melia Russell | ) www.businessinsider.com   time to read: +7 min
Kai Micah Mills is a rare cryonics entrepreneur in the latest batch of Thiel Fellows. His startup Cryopets aims to establish a chain of animal hospitals set up to freeze pets upon death. When he was 14, Kai Micah Mills brought home a long-haired tabby cat and named it Cat. Someday, he hopes to expand to human preservation, as the science matures and pet owners warm to the idea. Mills hasn't figured out a pricing structure yet, but says pet owners will make a payment that covers their pet's storage for as long as necessary.
☆ Sam Altman gave us ChatGPT. Now he wants us to defy death.
  + stars: | 2023-03-09 | by ( Cheryl Teh | ) www.businessinsider.com   time to read: +4 min
Sam Altman put $180 million into Retro Biosciences, a company that aims to delay death by 10 years. Altman's interest in longevity research dates back at least eight years, per the MIT Technology Review. I basically just took all my liquid net worth and put it into these two companies," Altman told the MIT Technology Review. According to the MIT Technology Review, Altman has been interested in anti-aging methods for years. Altman told the MIT Technology Review that the success of this experiment was something he "didn't expect."
☆ OpenAI's 37-year-old CEO bet $180 million on a little-known biotech startup that's trying to help people live 10 years longer
  + stars: | 2023-03-09 | by ( Yeji Jesse Lee | ) www.businessinsider.com   time to read: +3 min
According to a report by MIT Technology Review, OpenAI CEO Sam Altman is among the group. Altman has quietly funded a longevity startup with $180 million, MIT Technology Review said. The latest addition to the group is Sam Altman, the 37-year-old CEO of the red-hot AI startup OpenAI. Altman quietly backed a mysterious longevity startup called Retro Biosciences with $180 million of his own funds, according to a report in MIT Technology Review. "The main thing for Retro is to be a really good bio startup, because that is a rare thing," Altman told MIT Technology Review.
☆ OpenAI’s Sam Altman is the latest tech entrepreneur making a play to extend the human lifespan. Here are 15 of the world's wealthiest entrepreneurs trying to crack the code of living forever.
  + stars: | 2023-03-08 | by ( Lakshmi Varanasi | ) www.businessinsider.com   time to read: +1 min
Sam AltmanOpenAI's Sam Altman reportedly invested $180 million into a longevity startup called Retro Biosciences, according to MIT Technology Review. Lucy Nicholson/ReutersSam Altman is quickly establishing himself as a household name as the CEO of OpenAI, the company behind ChatGPT. Altman seems to be channeling some of his probable largesse into extending the human lifespan. MIT Technology Review reported that Altman invested $180 million into Retro Biosciences, a company with a mission to "add 10 years to healthy human lifespan," according to the company's site. Altman's investment in Retro Biosciences is among the "largest ever by an individual into a startup pursuing human longevity," MTR said.
☆ OpenAI CEO Sam Altman takes diabetes drug metformin as part of his anti-aging routine
  + stars: | 2023-03-08 | by ( Aaron Mok | ) www.businessinsider.com   time to read: +3 min
OpenAI CEO Sam Altman takes the diabetes drug metformin to slow down aging. Metformin is a decades-old drug that is prescribed to millions of people with diabetes, CNBC reported. In addition to the drug, Altman's said his anti-aging regimen includes "trying to eat healthy, exercise, and sleep enough," per the MIT Technology Review. The company uses genetic engineering and plasma replacement to make cells younger, per the MIT Technology Review. Altman secretly poured $180 million dollars into Retro Bioscience's death-delaying treatment, the MIT Technology Review reported.
0 next >>
Total: 13